Diagnosis and treatment of pulmonary arterial hypertension: a review

NF Ruopp, BA Cockrill - Jama, 2022 - jamanetwork.com
Importance Pulmonary arterial hypertension (PAH) is a subtype of pulmonary hypertension
(PH), characterized by pulmonary arterial remodeling. The prevalence of PAH is …

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary …

M Humbert, G Kovacs, MM Hoeper… - European heart …, 2022 - academic.oup.com
Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

[HTML][HTML] COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension

MM Hoeper, C Pausch, KM Olsson… - European …, 2022 - Eur Respiratory Soc
Background Risk stratification plays an essential role in the management of patients with
pulmonary arterial hypertension (PAH). The current European guidelines propose a three …

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

M Humbert, G Kovacs, MM Hoeper… - European …, 2023 - Eur Respiratory Soc
Guidelines summarize and evaluate available evidence, with the aim of assisting health
professionals in proposing the best management strategies for an individual patient with a …

[HTML][HTML] Temporal trends in pulmonary arterial hypertension: results from the COMPERA registry

MM Hoeper, C Pausch, E Grünig… - European …, 2022 - Eur Respiratory Soc
Background Since 2015, the European pulmonary hypertension guidelines recommend the
use of combination therapy in most patients with pulmonary arterial hypertension (PAH) …

Mortality in pulmonary arterial hypertension in the modern era: early insights from the pulmonary hypertension association registry

KY Chang, S Duval, DB Badesch, TM Bull… - Journal of the …, 2022 - Am Heart Assoc
Background Current mortality data for pulmonary arterial hypertension (PAH) in the United
States are based on registries that enrolled patients prior to 2010. We sought to determine …

Pathophysiology and pathogenic mechanisms of pulmonary hypertension: role of membrane receptors, ion channels, and Ca2+ signaling

A Balistrieri, A Makino, JXJ Yuan - Physiological Reviews, 2023 - journals.physiology.org
The pulmonary circulation is a low-resistance, low-pressure, and high-compliance system
that allows the lungs to receive the entire cardiac output. Pulmonary arterial pressure is a …

Aggressive afterload lowering to improve the right ventricle: a new target for medical therapy in pulmonary arterial hypertension?

CD Vizza, IM Lang, R Badagliacca… - American journal of …, 2022 - atsjournals.org
Despite numerous therapeutic advances in pulmonary arterial hypertension, patients
continue to suffer high morbidity and mortality, particularly considering a median age of 50 …

Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies

H Christou, RA Khalil - American Journal of Physiology …, 2022 - journals.physiology.org
Pulmonary hypertension (PH) is a serious disease characterized by various degrees of
pulmonary vasoconstriction and progressive fibroproliferative remodeling and inflammation …

[HTML][HTML] Mortality trends in pulmonary arterial hypertension in Canada: a temporal analysis of survival per ESC/ERS guideline era

JGE Zelt, J Sugarman, J Weatherald… - European …, 2022 - Eur Respiratory Soc
Background The evolution in pulmonary arterial hypertension (PAH) management has been
summarised in three iterations of the European Society of Cardiology/European Respiratory …